Public Education · Research Translation · Access Advocacy
The Founding Story.
Jess did not arrive at this work through theory. She arrived through suffering, collapse, and the search for something that could reach what conventional care could not.
The breaking point
For years, Jess lived inside patterns she could not explain, stop, or properly name. Her undiagnosed Borderline Personality Disorder shaped her relationships, her sense of self, and her ability to recognize danger while she was inside it. That confusion led her into a sexually abusive relationship that deepened the damage already taking place.
When she finally sought help, she received a diagnosis. But instead of relief, she was met with a devastating message repeated across the literature: personality disorders were not considered curable. Even the more hopeful outlooks around BPD suggested a painfully long road—often framed as 15 to 30 years of therapy just to reach a survivable life.
The search for another path
Jess refused to believe management was the best life had to offer. Around that time, Ben had begun studying psilocybin closely, researching its psychological effects and the emerging evidence around healing, neuroplasticity, and trauma.
Together, they explored the compound carefully for about a year. Then, on October 14, 2023, they made a more serious commitment: Jess began taking 6 grams of psilocybin one to two times a week as part of an intentional long-term healing process.
What changed
The long-term benefits Jess experienced felt nothing short of miraculous. She describes healing from severe bulimia, a life-threatening autoimmune condition that once landed her in the hospital, and patterns of eating that had kept her body in distress. Her relationship to sugar and food shifted dramatically. She also began processing and healing sexual trauma that had remained embedded in her nervous system and identity.
Most importantly, she experienced deep internal changes in the personality-level suffering that had once defined her life. She describes real movement in the symptoms associated with BPD, narcissism, and sociopathy—and, for the first time, access to genuine empathy not as performance, but as feeling.
Why this project exists
Living in Colorado, Jess and Ben expected to find a movement aligned with healing and public good. Instead, they began to see a therapeutic model becoming financially out of reach for the very people who needed it most. While equitable access appears in the legislation, the real-world cost structure often makes that promise feel unreachable.
So they started this nonprofit with a simple conviction: safe, psychologically informed access to healing should not be reserved for people with money, status, or elite institutional access.
The vision
Their goal is to help create a model where psychedelic healing can move from a $2,000–$10,000 private clinical experience toward something under $100, grounded in education, peer support, safety, and accessibility.
This is not just Jess’s story. It is the reason this work began.